Fabian Maass

1.2k total citations
34 papers, 879 citations indexed

About

Fabian Maass is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Fabian Maass has authored 34 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 10 papers in Physiology and 9 papers in Molecular Biology. Recurrent topics in Fabian Maass's work include Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (8 papers) and Alzheimer's disease research and treatments (6 papers). Fabian Maass is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), Neurological disorders and treatments (8 papers) and Alzheimer's disease research and treatments (6 papers). Fabian Maass collaborates with scholars based in Germany, Spain and Slovakia. Fabian Maass's co-authors include Paul Lingor, Mathias Bähr, Anna‐Elisa Roser, Lucas Caldi Gomes, Inga Zerr, Andreas Leha, Lars Tönges, Ingrid Grummt, Holger Bierhoff and Andreas Wree and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Fabian Maass

34 papers receiving 870 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabian Maass Germany 17 314 270 228 131 105 34 879
Anna Paterlini Italy 17 304 1.0× 232 0.9× 441 1.9× 59 0.5× 123 1.2× 25 784
Kensaku Kasuga Japan 19 420 1.3× 386 1.4× 572 2.5× 111 0.8× 203 1.9× 74 1.2k
Giulia Ambrosi Italy 17 347 1.1× 324 1.2× 175 0.8× 57 0.4× 124 1.2× 26 941
Valeria Valsecchi Italy 23 735 2.3× 188 0.7× 168 0.7× 176 1.3× 136 1.3× 44 1.3k
Stuart Portbury Australia 14 424 1.4× 103 0.4× 252 1.1× 77 0.6× 78 0.7× 19 1.1k
Wei Qian China 18 522 1.7× 100 0.4× 448 2.0× 31 0.2× 94 0.9× 32 997
Antonio Vinciguerra Italy 22 462 1.5× 135 0.5× 133 0.6× 180 1.4× 190 1.8× 43 1.0k
Philip Stavrides United States 17 566 1.8× 192 0.7× 924 4.1× 56 0.4× 227 2.2× 25 1.7k
Ze‐Xu Wei China 7 373 1.2× 126 0.5× 90 0.4× 194 1.5× 89 0.8× 9 765
Steffen E. Storck Germany 15 276 0.9× 110 0.4× 570 2.5× 80 0.6× 306 2.9× 21 1.1k

Countries citing papers authored by Fabian Maass

Since Specialization
Citations

This map shows the geographic impact of Fabian Maass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Maass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Maass more than expected).

Fields of papers citing papers by Fabian Maass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Maass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Maass. The network helps show where Fabian Maass may publish in the future.

Co-authorship network of co-authors of Fabian Maass

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Maass. A scholar is included among the top collaborators of Fabian Maass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Maass. Fabian Maass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maass, Fabian, Christoph van Riesen, Péter Hermann, et al.. (2024). Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions. Journal of Neurology. 272(1). 52–52. 4 indexed citations
2.
Tatenhorst, Lars, Fabian Maass, Hannah Paul, et al.. (2024). Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease. Scientific Reports. 14(1). 5005–5005. 2 indexed citations
3.
Carmona, Asunción, Eleonora Carboni, Lucas Caldi Gomes, et al.. (2024). Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. Journal of Neurochemistry. 168(2). 128–141. 11 indexed citations
4.
Maass, Fabian, et al.. (2023). Spinocerebellar Ataxia Type 35 Caused by a New TGM6 Variant: Video Documentation of a German Family. Movement Disorders Clinical Practice. 10(6). 1016–1019. 1 indexed citations
5.
Schmitz, Matthias, Juan Carlos Espinosa, Natalia Fernández‐Borges, et al.. (2022). Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease. Molecular Neurobiology. 59(9). 1–9. 8 indexed citations
6.
Hermann, Péter, Daniela Varges, Stefan Goebel, et al.. (2022). Baseline Cerebrospinal Fluid α-Synuclein in Parkinson’s Disease Is Associated with Disease Progression and Cognitive Decline. Diagnostics. 12(5). 1259–1259. 1 indexed citations
7.
Maass, Fabian, Sivaraj Mohana Sundaram, Brit Mollenhauer, et al.. (2022). The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease. Molecular and Cellular Neuroscience. 121. 103746–103746. 8 indexed citations
8.
Schmitz, Matthias, Anna Villar‐Piqué, Fabian Maass, et al.. (2021). Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies. Frontiers in Aging Neuroscience. 13. 717930–717930. 20 indexed citations
9.
Koch, Jan Christoph, et al.. (2020). Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis. Frontiers in Neurology. 11. 173–173. 38 indexed citations
10.
Maass, Fabian, Vivian Dambeck, Lars Tatenhorst, et al.. (2020). Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease. Scientific Reports. 10(1). 8507–8507. 43 indexed citations
11.
Maass, Fabian, et al.. (2019). Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease. Cells. 8(2). 105–105. 31 indexed citations
12.
Maass, Fabian, Bernhard Michalke, Desiree Willkommen, et al.. (2019). Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease. Neurobiology of Disease. 134. 104677–104677. 33 indexed citations
13.
Roser, Anna‐Elisa, et al.. (2019). The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System. Frontiers in Neuroscience. 13. 15–15. 83 indexed citations
14.
Maass, Fabian, Bernhard Michalke, Andreas Leha, et al.. (2018). Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease. Journal of Neurochemistry. 145(4). 342–351. 42 indexed citations
15.
Roser, Anna‐Elisa, Lucas Caldi Gomes, Rashi Halder, et al.. (2018). miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons. Molecular Therapy — Nucleic Acids. 11. 9–22. 39 indexed citations
16.
Maass, Fabian, et al.. (2018). Bioelemental patterns in the cerebrospinal fluid as potential biomarkers for neurodegenerative disorders. Neural Regeneration Research. 13(8). 1356–1356. 5 indexed citations
17.
Maass, Fabian, et al.. (2018). Cerebrospinal fluid biomarker for Parkinson's disease: An overview. Molecular and Cellular Neuroscience. 97. 60–66. 33 indexed citations
18.
Maass, Fabian, Jana Petersen, Marina Hovakimyan, et al.. (2014). Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: A mouse model of Niemann‐Pick type C1 disease. Journal of Neuroscience Research. 93(3). 433–442. 18 indexed citations
19.
Hovakimyan, Marine, Jana Petersen, Fabian Maass, et al.. (2011). Corneal Alterations during Combined Therapy with Cyclodextrin/Allopregnanolone and Miglustat in a Knock-Out Mouse Model of NPC1 Disease. PLoS ONE. 6(12). e28418–e28418. 6 indexed citations
20.
Bierhoff, Holger, et al.. (2010). Noncoding Transcripts in Sense and Antisense Orientation Regulate the Epigenetic State of Ribosomal RNA Genes. Cold Spring Harbor Symposia on Quantitative Biology. 75(0). 357–364. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Paterlini Breakdown of academic impact, for papers by Kensaku Kasuga Breakdown of academic impact, for papers by Giulia Ambrosi Breakdown of academic impact, for papers by Valeria Valsecchi Breakdown of academic impact, for papers by Stuart Portbury Breakdown of academic impact, for papers by Wei Qian Breakdown of academic impact, for papers by Antonio Vinciguerra Breakdown of academic impact, for papers by Philip Stavrides Breakdown of academic impact, for papers by Ze‐Xu Wei Breakdown of academic impact, for papers by Steffen E. Storck
Rankless by CCL
2026